Hillhouse Capital Advisors as of Sept. 30, 2019
Portfolio Holdings for Hillhouse Capital Advisors
Hillhouse Capital Advisors holds 64 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Iqiyi (IQ) | 11.2 | $815M | 51M | 16.13 | |
Beigene (BGNE) | 9.2 | $670M | 5.5M | 122.46 | |
TAL Education (TAL) | 6.7 | $487M | 14M | 34.24 | |
Jd (JD) | 6.2 | $455M | 16M | 28.21 | |
Uber Technologies (UBER) | 5.2 | $376M | 12M | 30.47 | |
Sea Ltd Adr Isin Us81141r1005 (SE) | 5.1 | $370M | 12M | 30.95 | |
Alibaba Group Holding (BABA) | 5.0 | $364M | 2.2M | 167.23 | |
Pinduoduo (PDD) | 4.9 | $359M | 11M | 32.22 | |
Enstar Group (ESGR) | 4.6 | $332M | 1.7M | 189.92 | |
China Biologic Products | 4.3 | $315M | 2.8M | 114.47 | |
New Oriental Education & Tech | 4.2 | $306M | 2.8M | 110.76 | |
Align Technology (ALGN) | 3.9 | $283M | 1.6M | 180.92 | |
Facebook Inc cl a (META) | 3.1 | $228M | 1.3M | 178.08 | |
Bilibili Ads (BILI) | 2.5 | $181M | 13M | 14.12 | |
Mondelez Int (MDLZ) | 1.9 | $141M | 2.5M | 55.32 | |
Fibrogen (FGEN) | 1.8 | $130M | 3.5M | 36.98 | |
Apellis Pharmaceuticals (APLS) | 1.6 | $113M | 4.7M | 24.09 | |
Blueprint Medicines (BPMC) | 1.5 | $110M | 1.5M | 73.47 | |
Gossamer Bio (GOSS) | 1.4 | $99M | 5.9M | 16.79 | |
Bridgebio Pharma (BBIO) | 1.3 | $94M | 4.4M | 21.47 | |
Melco Crown Entertainment (MLCO) | 1.2 | $85M | 4.4M | 19.41 | |
Amazon (AMZN) | 1.2 | $84M | 49k | 1735.90 | |
Snap Inc cl a (SNAP) | 1.0 | $71M | 4.5M | 15.80 | |
Netflix (NFLX) | 1.0 | $70M | 261k | 267.62 | |
Myokardia | 0.7 | $51M | 976k | 52.15 | |
Covetrus | 0.7 | $47M | 4.0M | 11.89 | |
Line Corp- | 0.6 | $43M | 1.2M | 35.94 | |
Momo | 0.6 | $43M | 1.4M | 30.98 | |
Tesla Motors (TSLA) | 0.6 | $41M | 171k | 240.87 | |
Smiledirectclub (SDCCQ) | 0.6 | $41M | 2.9M | 13.88 | |
Bright Scholar Ed Hldgs | 0.5 | $39M | 4.0M | 9.67 | |
Nextcure (NXTC) | 0.5 | $33M | 1.1M | 30.85 | |
Genmab A/s -sp (GMAB) | 0.4 | $30M | 1.5M | 20.26 | |
Apple (AAPL) | 0.4 | $29M | 128k | 223.97 | |
Square Inc cl a (SQ) | 0.4 | $27M | 429k | 61.95 | |
Mogu Inc-adr spon ads | 0.4 | $26M | 10M | 2.51 | |
Zai Lab (ZLAB) | 0.3 | $26M | 798k | 32.35 | |
Uxin Ltd ads | 0.3 | $23M | 9.4M | 2.45 | |
G1 Therapeutics (GTHX) | 0.3 | $22M | 949k | 22.78 | |
Nio Inc spon ads (NIO) | 0.3 | $21M | 13M | 1.56 | |
Huazhu Group (HTHT) | 0.3 | $20M | 612k | 33.02 | |
MercadoLibre (MELI) | 0.2 | $18M | 33k | 551.23 | |
Arvinas Ord (ARVN) | 0.2 | $18M | 855k | 21.55 | |
Akero Therapeutics (AKRO) | 0.2 | $17M | 749k | 22.75 | |
Regenxbio Inc equity us cm (RGNX) | 0.2 | $16M | 456k | 35.60 | |
Kiniksa Pharmaceuticals (KNSA) | 0.2 | $16M | 1.9M | 8.51 | |
Moderna (MRNA) | 0.2 | $16M | 978k | 15.92 | |
Noah Holdings (NOAH) | 0.2 | $14M | 481k | 29.20 | |
Sohu (SOHU) | 0.1 | $8.1M | 802k | 10.16 | |
Arcus Biosciences Incorporated (RCUS) | 0.1 | $7.0M | 767k | 9.10 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $7.1M | 943k | 7.50 | |
Eidos Therapeutics | 0.1 | $6.4M | 179k | 35.97 | |
Igm Biosciences (IGMS) | 0.1 | $6.2M | 350k | 17.75 | |
China Jo Jo Drugstores | 0.1 | $5.9M | 4.8M | 1.21 | |
Tcr2 Therapeutics Inc cs | 0.1 | $4.9M | 323k | 15.03 | |
Cellular Biomedicine Group I | 0.1 | $3.5M | 235k | 14.86 | |
10x Genomics Inc Cl A (TXG) | 0.1 | $3.8M | 75k | 50.40 | |
58 Com Inc spon adr rep a | 0.0 | $2.9M | 58k | 49.31 | |
Constellation Pharmceticls I | 0.0 | $1.6M | 247k | 6.46 | |
China Index Holdings | 0.0 | $1.2M | 300k | 3.90 | |
Puxin Ltd ads | 0.0 | $1.0M | 126k | 7.97 | |
Gs Acquisition Hldgs Corp *w exp 06/12/202 | 0.0 | $453k | 333k | 1.36 | |
Fang Holdings | 0.0 | $666k | 300k | 2.22 | |
Neon Therapeutics | 0.0 | $103k | 60k | 1.72 |